Clinical Trial: Validation of THRIVE and CLEOS Prognostic Models in Taiwanese Patients Undergoing Stroke Thrombectomy

U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07921875) titled 'Validation of THRIVE and CLEOS Prognostic Models in Taiwanese Patients Undergoing Stroke Thrombectomy' on Nov. 02.

Brief Summary: This study will examine how well two existing prediction tools, THRIVE and CLEOS, predict recovery after a stroke caused by a blockage in a large blood vessel in the brain. It will review the medical records of adults who underwent endovascular thrombectomy, a procedure that removes the blood clot, at Kuang Tien General Hospital in Taiwan.

THRIVE uses age, stroke severity, and certain existing medical conditions. CLEOS uses age, stroke severity, blood glucose, and information from brain imaging. The study...